Is gemcitabine cost effective in cancer treatment? - Wikidata - awgldk - TriplyDB

Is gemcitabine cost effective in cancer treatment?

Is gemcitabine cost effective in cancer treatment?

http://www.wikidata.org/entity/Q43042833

about

Everolimus enhances gemcitabine-induced cytotoxicity in bladder-cancer cell lines.

P2860

Q39315907-AC48B633-1028-4AA1-87D6-A4AEA8753D7A

P2860

Is gemcitabine cost effective in cancer treatment?

http://www.wikidata.org/entity/Q43042833

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Is gemcitabine cost effective in cancer treatment?

@en

Is gemcitabine cost effective in cancer treatment?

@nl

type

label

Is gemcitabine cost effective in cancer treatment?

@en

Is gemcitabine cost effective in cancer treatment?

@nl

prefLabel

Is gemcitabine cost effective in cancer treatment?

@en

Is gemcitabine cost effective in cancer treatment?

@nl

P1433

Q43042833-6DC8D9E0-F7DC-4443-8B58-642D5A5AC1B9

P1476

Q43042833-812AFBB7-F167-4D08-B7E8-0AFFAAC67995

P2093

Q43042833-27D0AED2-9933-40F5-80CC-1478C3481434

Q43042833-9456195F-83A9-478F-9512-B2AFD9DA35B1

Q43042833-9BA20D79-41C4-4EB6-BE5E-5AA1B27918F8

Q43042833-BFA5227E-0365-4B91-B3D5-1843E36D0311

Q43042833-D654F25F-9660-4810-BA1E-8CD491CA7549

Q43042833-F3998E02-0EF2-4FC9-A12B-B31CBB6653A4

Q43042833-F5B5063B-A65E-477A-BA2A-A2ED597EB202

Q43042833-F775B38F-2916-43E9-AA1B-73AA1B3BF922

P2860

Q43042833-04E255A0-CEA0-4E51-A956-21D50565DD40

Q43042833-1F9346CA-3296-4030-A1FA-88B34C02BFF7

Q43042833-20FFC1D7-CB3A-4D5D-B50F-22E2B231E0DF

Q43042833-2189DAC1-AB97-4950-AB7D-790B080A6C59

Q43042833-26947C03-6AA4-4A4C-9427-5F267EACBC51

Q43042833-285480B9-8A99-41E7-941D-7DE9E72B1896

Q43042833-2B547119-D2DD-4739-BA8A-ED92C6E9718B

Q43042833-31450832-2828-4596-8B53-B049FB86620B

Q43042833-3702231D-8669-432C-965D-92F98D316C3D

Q43042833-3E594873-A126-48C6-91BB-98A29A331DAE

P304

Q43042833-076CF5BE-CB92-48DC-B2CC-3617F331314C

P31

Q43042833-1C4E36F9-8179-4C53-A7CA-6A5D2073406F

P356

Q43042833-4E06B66F-B455-4009-A7D9-6A30E406A87A

P433

Q43042833-4D46E860-21F0-4E15-8DB8-4019C2B17A86

P478

Q43042833-16FD12D9-134D-4E33-8B63-CE0DD8A7142F

P50

Q43042833-B7B964C8-2008-4840-A008-12C87121BF38

P577

Q43042833-7C863F81-26F3-4525-AF4E-66A7C08D0702

P698

Q43042833-D3A5BFE7-B1C4-445E-AEF7-7ADACF6EC4BE

P356

14737167.7.3.239

P1433

Expert Review of Pharmacoeconomics & Outcomes Research

P1476

Is gemcitabine cost effective in cancer treatment?

@en

P2093

Armando Santoro

http://www.w3.org/2001/XMLSchema#string

Fabio De Vincenzo

http://www.w3.org/2001/XMLSchema#string

Giovanna Finocchiaro

http://www.w3.org/2001/XMLSchema#string

Giovanni Luca Ceresoli

http://www.w3.org/2001/XMLSchema#string

Isabella Garassino

http://www.w3.org/2001/XMLSchema#string

Luca Toschi

http://www.w3.org/2001/XMLSchema#string

Paolo Andrea Zucali

http://www.w3.org/2001/XMLSchema#string

Raffaele Cavina

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine.

Single-agent gemcitabine is active in previously treated metastatic breast cancer.

Gemcitabine as first-line therapy in patients with metastatic breast cancer: a phase II trial.

Paclitaxel plus carboplatin, compared with paclitaxel plus gemcitabine, shows similar efficacy while more cost-effective: a randomized phase II study of combination chemotherapy against inoperable non-small-cell lung cancer previously untreated.

Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in advanced non-small-cell lung cancer: a phase III randomized trial.

Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer.

Multicentre randomised phase III study comparing the same dose and schedule of cisplatin plus the same schedule of vinorelbine or gemcitabine in advanced non-small cell lung cancer.

Gemcitabine monotherapy as salvage chemotherapy in heavily pretreated metastatic breast cancer.

P304

239-249

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737167.7.3.239

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Federico Cappuzzo

P577

2007-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20528311

http://www.w3.org/2001/XMLSchema#string